CGH
JAZZ icon

Crossmark Global Holdings’s Jazz Pharmaceuticals JAZZ Stock Holding History

Crossmark Global Holdings’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.74M Buy
7,237
+703
+11% +$154K 0.02% 490
2026
Q1 		$1.24M Buy
6,534
+347
+6% +$60.6K 0.02% 546
2025
Q4 		$1.05M Buy
6,187
+2,513
+68% +$385K 0.02% 587
2025
Q3 		$484K Sell
3,674
-10,433
-74% -$1.25M 0.01% 911
2025
Q2 		$1.5M Buy
14,107
+9,674
+218% +$1.05M 0.02% 506
2025
Q1 		$550K Sell
4,433
-492
-10% -$64.2K 0.01% 837
2024
Q4 		$607K Sell
4,925
-158
-3% -$18.6K 0.01% 751
2024
Q3 		$567K Buy
5,083
+970
+24% +$106K 0.01% 815
2024
Q2 		$439K Sell
4,113
-1,009
-20% -$111K 0.01% 888
2024
Q1 		$617K Sell
5,122
-42
-0.8% -$5.14K 0.01% 770
2023
Q4 		$636K Sell
5,164
-787
-13% -$98.2K 0.01% 748
2023
Q3 		$775K Sell
5,951
-4,562
-43% -$608K 0.02% 651
2023
Q2 		$1.38M Sell
10,513
-74
-0.7% -$9.96K 0.03% 510
2023
Q1 		$1.55M Buy
10,587
+3,563
+51% +$527K 0.04% 470
2022
Q4 		$1.12M Buy
7,024
+1,115
+19% +$163K 0.03% 535
2022
Q3 		$788K Buy
5,909
+50
+0.9% +$7.6K 0.02% 619
2022
Q2 		$914K Sell
5,859
-60
-1% -$9.24K 0.02% 599
2022
Q1 		$922K Buy
5,919
+240
+4% +$34.8K 0.02% 652
2021
Q4 		$724K Sell
5,679
-710
-11% -$93.3K 0.02% 753
2021
Q3 		$832K Sell
6,389
-150
-2% -$22.7K 0.02% 670
2021
Q2 		$1.16M Buy
6,539
+295
+5% +$51.1K 0.03% 562
2021
Q1 		$1.03M Buy
6,244
+90
+1% +$14.8K 0.03% 586
2020
Q4 		$1.02M Buy
6,154
+1,150
+23% +$171K 0.03% 573
2020
Q3 		$714K Buy
+5,004
New +$620K 0.02% 638
2018
Q4 		– Sell
-2,610
Closed -$439K – 1471
2018
Q3 		$439K Buy
2,610
+120
+5% +$20.6K 0.01% 1048
2018
Q2 		$429K Buy
+2,490
New +$407K 0.01% 1048

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
PCM
Poehling Capital Management Madison, Wisconsin $466M AUM 24.17% 1-Year Est. Return

Crossmark Global Holdings's JAZZ Position: Q2 2026 in Review

Crossmark Global Holdings increased its Jazz Pharmaceuticals (JAZZ) stake by 11% in Q2 2026, buying an estimated $154K and bringing the position to 7,237 shares worth $1.74M. The position accounts for 0.02% of the portfolio, ranked #490.

Crossmark Global Holdings first reported a position in JAZZ in Q2 2018 and has held it in 26 quarters since. 76 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Crossmark Global Holdings held 7,237 shares of Jazz Pharmaceuticals worth $1.74M as of Q2 2026.
  • Crossmark Global Holdings bought 703 Jazz Pharmaceuticals shares in Q2 2026, an estimated $154K.
  • Jazz Pharmaceuticals made up 0.02% of Crossmark Global Holdings's portfolio in Q2 2026, its #490 holding.
  • Crossmark Global Holdings first reported a position in Jazz Pharmaceuticals in Q2 2018 and has held it in 26 quarters since.
  • 76 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.